Finance

The Axalta Deal: Is AkzoNobel taking the lead?

23 November, 2017 author:Rutger Bloemenkamp

Due to a takeover battle with PPG, AkzoNobel has been in an unstable situation. Are they taking back the lead?

Blockchain for Dummies

20 October, 2017 author:Rob Donkers

Our editor Rob Donkers introduces you to blockchain without making it too complicated. Will it change the world as we know it?

Interview with Roel van de Ven

5 October, 2017 author:Luc van den Hurk & Rob Donkers

Roel van de Ven is a former board member of Asset | Accounting & Finance. Currently, he works at the Rabobank Agri & Food sector. Read his story here!

Quantitative Easing: monetary miracle or too good to be true?

29 September, 2017 author:Jan-Paul Kempen

Jan-Paul Kempen discusses the policy that central banks have accomplished since the financial crisis in 2008.

Gilead Sciences: Can it do its namesake proud?

19 September, 2017 author:Rutger Bloemenkamp

From June 19 2017 until September 12 2017, the share price of Gilead Sciences surged from $64.23 to $84.52 per share. Read more about Gilead Sciences here!

Interview Olaf van den Heuvel, European Head of Tactical Asset Allocation

8 June, 2017 author:Krijn van den Broek & Djanmar Sorber

Olaf van den Heuvel is the European Head of the Asset Tactical Allocation at Aegon Asset Management. In this interview he gives you insight in his tasks.